Home
Storia in 1 fonti
Cellares' recent automated cell therapy wins have 'opened the biotech floodgates'
After speedrunning a series of major manufacturing milestones in the past year and a half, the “biotech floodgates” have opened for Cellares, the automated cell therapy manufacturing specialist’s c | After speedrunning a series of major manufacturing milestones in the past year-and-a-half, the “biotech floodgates” have opened for Cellares, the automated cell therapy manufacturing specialist’s co-founder and CEO told Fierce Pharma Manufacturing.
Raccontata da
fiercepharma.com
Timeline cronologica
- ·
Clinical Success Is No Longer One Number
By Andreas Dimakakos Director of Clinical Data, Kate Smietana Director, Knowledge and Thought Leadership, Panos Karelis VP of Commercial, Dimitris Skaltsas Co-founder & CEO | In…
- ·
Cellares' recent automated cell therapy wins have 'opened the biotech floodgates'
After speedrunning a series of major manufacturing milestones in the past year and a half, the “biotech floodgates” have opened for Cellares, the automated cell therapy…
- ·
With FDA approval for its breast cancer blockbuster hopeful, Celcuity could ‘belong in the hands’ of a Big Pharma
The FDA has approved a new | The FDA has approved a new small molecule inhibitor from Celcuity with blockbuster potential that could become a new standard-of-care for patients…